The identification of phenotypes in patients with severe Chronic Obstructive Pulmonary Disease

Completed

• Conditions: Chronic Obstructive Pulmonary Disease (COPD); emphysema; 10038716

• Registration Number: NL-OMON40211
• Lead Sponsor: niversitair Medisch Centrum Groningen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 1000

Inclusion Criteria

• Referral to the LVR intervention team or LTx team of the UMCG.
• Chronic Obstructive Pulmonary Disease (COPD) according the Global initiative for Chronic Obstructive Lung Disease (GOLD) criteria (post bronchodilator FEV1/FVC < 0.7)
• Written informed consent.

Exclusion Criteria

There are no exclusion criteria for this study.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The main study parameter is the identification of new clinical phenotypes. The<br /><br>collected data will allow us to identify new phenotypes, clusters of patients<br /><br>with similar characteristics. These phenotypes are potentially based on a<br /><br>combination of lung function parameters, clinical parameters, radiologic<br /><br>parameters, and systemic parameters and genotypes and endotypes, in patients<br /><br>with severe COPD.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>NA</p><br>